Tower Research Capital (TRC)’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-9,332
| Closed | -$27.7K | – | 5683 |
|
|
2025
Q2 | $27.7K | Buy |
9,332
+6,184
| +196% | +$18K | ﹤0.01% | 3465 |
|
|
2025
Q1 | $10.2K | Sell |
3,148
-1,051
| -25% | -$3.62K | ﹤0.01% | 3668 |
|
|
2024
Q4 | $16.6K | Buy |
4,199
+2,808
| +202% | +$19.1K | ﹤0.01% | 3349 |
|
|
2024
Q3 | $10.8K | Buy |
1,391
+1,358
| +4,115% | +$8.92K | ﹤0.01% | 3722 |
|
|
2024
Q2 | $170 | Sell |
33
-1,084
| -97% | -$8.36K | ﹤0.01% | 5424 |
|
|
2024
Q1 | $9.08K | Buy |
1,117
+1,065
| +2,048% | +$6.1K | ﹤0.01% | 3901 |
|
|
2023
Q4 | $208 | Buy |
+52
| New | +$207 | ﹤0.01% | 5650 |
|
|
2023
Q2 | – | Sell |
-236
| Closed | -$1K | – | 6394 |
|
|
2023
Q1 | $1K | Buy |
236
+65
| +38% | +$242 | ﹤0.01% | 5631 |
|
|
2022
Q4 | $1K | Sell |
171
-2,400
| -93% | -$8.18K | ﹤0.01% | 5684 |
|
|
2022
Q3 | $9K | Sell |
2,571
-28,057
| -92% | -$132K | ﹤0.01% | 4705 |
|
|
2022
Q2 | $172K | Buy |
30,628
+28,003
| +1,067% | +$188K | ﹤0.01% | 1883 |
|
|
2022
Q1 | $23K | Buy |
2,625
+1,374
| +110% | +$13.8K | ﹤0.01% | 3408 |
|
|
2021
Q4 | $14K | Buy |
1,251
+451
| +56% | +$5.87K | ﹤0.01% | 4120 |
|
|
2021
Q3 | $10K | Sell |
800
-704
| -47% | -$11.2K | ﹤0.01% | 4347 |
|
|
2021
Q2 | $25K | Sell |
1,504
-765
| -34% | -$13K | ﹤0.01% | 3694 |
|
|
2021
Q1 | $39K | Buy |
2,269
+1,568
| +224% | +$29.3K | ﹤0.01% | 3341 |
|
|
2020
Q4 | $11K | Sell |
701
-10,139
| -94% | -$187K | ﹤0.01% | 4264 |
|
|
2020
Q3 | $207K | Buy |
10,840
+8,369
| +339% | +$144K | ﹤0.01% | 2543 |
|
|
2020
Q2 | $34K | Buy |
2,471
+1,497
| +154% | +$21K | ﹤0.01% | 3364 |
|
|
2020
Q1 | $10K | Sell |
974
-3,951
| -80% | -$64.3K | ﹤0.01% | 2039 |
|
|
2019
Q4 | $92K | Buy |
+4,925
| New | +$63.4K | 0.01% | 988 |
|
|
2019
Q2 | – | Sell |
-2,586
| Closed | -$29K | – | 4384 |
|
|
2019
Q1 | $29K | Buy |
+2,586
| New | +$21K | ﹤0.01% | 2074 |
|
|
2018
Q1 | – | Sell |
-4,421
| Closed | -$17K | – | 3915 |
|
|
2017
Q4 | $17K | Buy |
+4,421
| New | +$18.6K | ﹤0.01% | 2199 |
|
|
2017
Q1 | – | Sell |
-610
| Closed | -$6K | – | 4016 |
|
|
2016
Q4 | $6K | Sell |
610
-390
| -39% | -$5.19K | ﹤0.01% | 2982 |
|
|
2016
Q3 | $13K | Hold |
1,000
| – | – | ﹤0.01% | 1895 |
|
|
2016
Q2 | $21K | Sell |
1,000
-1,281
| -56% | -$18.5K | ﹤0.01% | 2199 |
|
|
2016
Q1 | $22K | Buy |
+2,281
| New | +$18.9K | ﹤0.01% | 1283 |
|
|
2015
Q4 | – | Sell |
-2,068
| Closed | -$30K | – | 5117 |
|
|
2015
Q3 | $30K | Buy |
2,068
+1,217
| +143% | +$21.3K | ﹤0.01% | 1402 |
|
|
2015
Q2 | $16K | Buy |
+851
| New | +$17.7K | ﹤0.01% | 2299 |
|
Other funds holding XBIT
RC
Tower Research Capital (TRC)'s XBIT Position: Q3 2025 in Review
Tower Research Capital (TRC) sold out of XBiotech (XBIT) in Q3 2025, closing a stake of 9,332 shares — an estimated $27.7K sold.
Tower Research Capital (TRC) first reported a position in XBIT in Q2 2015 and held it in 29 quarters. The position peaked at $207K in Q3 2020. 48 funds tracked by Wall St. Rank hold XBIT as of Q3 2025.
- Tower Research Capital (TRC) reported no remaining XBiotech position as of Q3 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 9,332 XBiotech shares in Q3 2025, an estimated $27.7K.
- Tower Research Capital (TRC) first reported a position in XBiotech in Q2 2015 and held it in 29 quarters.
- Tower Research Capital (TRC)'s XBiotech position peaked at $207K in Q3 2020.
- 48 funds tracked by Wall St. Rank held XBiotech as of Q3 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.